Home Therapy With VPRIV in Gaucher's Disease

Update Il y a 4 ans
Reference: NCT01356537

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to proof increasing patient satisfaction and preservation of quality of life in patients with Gaucher's Disease receiving their enzyme replacement therapy with VPRIV (Velaglucerase alfa)at their home setting compared to receiving the infusions at the clinic or at doctor's practice.


Inclusion criteria

  • Gaucher Disease

Links